Headshot of Mel Soliz

Partner Mel Soliz Discusses Innovation in Health Equity and Barriers to its Growth at HIMSS’ Interoperability and HIE Forum

Health equity is the state in which everyone has a fair and just opportunity to attain their highest level of health. In her presentation to the Healthcare Information and Management Systems Society (HIMSS), Interoperability and Health Information Exchange Forum, Mel Soliz—Partner and leader of the firm’s interoperability practice—explained how health data interoperability and state and federal interoperability initiatives will advance health equity. Mel regularly speaks in local and national forums on interoperability and health equity. She is the President of the Arizona Society of Healthcare Attorneys and is recognized by Best Lawyers© and Southwest Super Lawyers: Rising Stars© for her work in health law....

Read MoreRead More
Headshot of Mel Soliz

Mel Soliz Presents a Health Care Training Webinar on the Information Blocking Rule (IBR) for Health Care Providers

Health care providers are prohibited from engaging in information blocking under the new federal Information Blocking Rule (IBR). Coppersmith Brockelman’s Partner Mel Soliz explains IBR requirements for health care providers in her educational webinar for Health Care Training. Mel covered the IBR’s background, enforcement structure and important deadlines; highlighted practices that implicate the prohibition on information blocking; IBR exceptions with a special focus on preventing harm, privacy, security, and content and manner; and best practices for IBR compliance. Mel regularly speaks in local and national forums on these topics and has been active in state and federal policy making on these issues. She is the President of the Arizona Society of Healthcare Attorneys and is recognized by Best Lawyers© and Southwest Super Lawyers: Rising Stars© for her...

Read MoreRead More
Headshot of Mel Soliz

Mel Soliz Delivers an Enlightening Presentation on FCA Liability and the Information Blocking Rule to the American Bar Association

Health care providers, health information networks/exchanges, and health IT developers must comply with the Information Blocking Rule (IBR). The IBR prohibits these actors from knowingly engaging in practices that are likely to interfere with the access, exchange or use of electronic health information (EHI), unless required by law or a regulatory exception applies. Melissa (Mel) Soliz, a Partner at Coppersmith Brockelman, explored IBR’s basic compliance requirements and the potential intersection between IBR compliance and False Claims Act (FCA) liability in her presentation to the American Bar Association. Mel regularly speaks in local and national forums on data privacy, access, and interoperability laws and is active in state and federal policy making on these issues. Heavily involved in her professional community, Mel is the President of the...

Read MoreRead More
Headshot of Mel Soliz

Mel Soliz Shares Insights on Data Access and Interoperability at Industry Events

A sought-after thought leader for nationwide events and webinars on health data access and interoperability, Mel Soliz recently spoke about information blocking, TEFCA and the 2021 Cures Act, while also taking time to help health law and clinical informatic students understand the career opportunities in the health data field. Mel’s most recent speaking engagements include: American Health Law Association (AHLA) Webinar Mel presented “To Boldly Go: Meeting Interoperability Requirements Under the 21st Century Cures Act” with her co-speakers before a virtual audience of more than 200 registrants. She covered the real life complexities faces by health care providers and payers in complying with the Information Blocking Rule and CMS interoperability mandates, as well as recent developments in health data interoperability policies, including the Trusted Exchange Framework and Common...

Read MoreRead More
ASU College of Health Solutions Lauds Mel Soliz’s Contributions to MDC Advisory Board

Mel Soliz Speaks at Health Current Summit about New Interoperability Rules

The deadlines to comply with new ONC and CMS interoperability, patient access, and information blocking rules are coming. Speaking at the Health Current Virtual Summit, Mel Soliz helped attendees understand the new rules and best practices to implement compliance. Health Current is Arizona’s primary resource for healthcare information technology and exchange, bringing together communities and information across Arizona. The organization helps more than 3,000 Arizona providers use information technology to improve people’s lives. Active in state and federal policymaking on data privacy and health information exchange, Mel frequently shares insights on these topics for local and national forums as well as industry publications. Additionally, she serves as a board member for the Arizona Society of Healthcare Attorneys.  Learn more about the Health Current Virtual Summit here. ...

Read MoreRead More
Kristen Rosati Reviews a Year of Health Law Updates for AHLA’s Annual Meeting

Kristen Rosati Explains Complicated Web of Laws Regulating Privacy in Oncology Treatment and Research at National Cancer Policy Forum

Kristen Rosati addressed the National Academies of Science, Engineering and Medicine National Cancer Policy Forum workshop on the role of digital health applications in oncology research and care. Kristen’s presentation addressed legal considerations around patient privacy and data security, in digital health applications. One of the nation’s leading “Big Data” and HIPAA compliance attorneys, Kristen focused on how the patient right of access, the patient right to direct disclosures to third parties, and the new information blocking and interoperability rules affect oncology digital health apps. She also provided an overview of privacy requirements for data sharing in cancer treatment and research, discussing the evolving standards for de-identification of genomic information.  With deep experience in data sharing for research and clinical integration initiatives, clinical research compliance, and biobanking and genomic...

Read MoreRead More